MYDAWA, a Kenyan online pharmacy startup, has received a $1.2 million grant from the Bill & Melinda Gates Foundation to increase access to PrEP (Pre-Exposure Prophylaxis) services through MYDAWA’s e-pharmacy model, supporting the fight against HIV& AIDS in Kenya.
Back in 2019, the startup raised $3m to scale its operations across the East African country by providing more access to affordable, genuine, and high-quality medicine as well as health care products.
The investment aims to generate evidence on virtual PrEP service delivery. A self-care model can expand the reach of PrEP through discreet and convenient delivery services.
Founded in 2017 by Neil O’Leary, MYDAWA is an innovative online platform that makes it easy to access affordable, authentic high-quality essential medicines, health and wellness products. It is the first fully licensed and regulated e-pharmacy in Kenya
“MYDAWA will adapt its current model that ensures a seamless end-to-end customer-centered delivery solution for those seeking PrEP across the country,” said MYDAWA chief executive officer (CEO) Tony Wood.
“Specifically, this investment will leverage on MYDAWA’s well-established model to expand PrEP delivery online. Together with the University of Washington, Jomo Kenyatta University of Agriculture and Technology, Fred Hutchinson Cancer Research Center, Jhpiego and Audere, we will develop this model, assess its feasibility, acceptability, and effectiveness in expanding the reach of PrEP. We will also generate necessary evidence and lessons learned to support policy change and further donor commitment towards this approach.”
